Editorial commentary: fifteen years of protection by meningococcal C conjugate vaccines: lessons from disease surveillance
- PMID: 25069870
- PMCID: PMC4191561
- DOI: 10.1093/cid/ciu599
Editorial commentary: fifteen years of protection by meningococcal C conjugate vaccines: lessons from disease surveillance
Keywords: Neisseria meningitidis; carriage; epidemics; herd immunity; vaccination.
Comment on
-
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.Clin Infect Dis. 2014 Nov 1;59(9):1208-15. doi: 10.1093/cid/ciu597. Epub 2014 Jul 28. Clin Infect Dis. 2014. PMID: 25069868
-
A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.Clin Infect Dis. 2014 Nov 1;59(9):1216-21. doi: 10.1093/cid/ciu601. Epub 2014 Jul 28. Clin Infect Dis. 2014. PMID: 25069869
References
-
- Sadarangani M, Scheifele DW, Halperin SA, et al. The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012. Clin Infect Dis. 2014;59:1208–15. - PubMed
-
- Bijlsma MW, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination. Clin Infect Dis. 2014;59:1216–21. - PubMed
-
- Conterno LO, Silva Filho CR, Ruggeberg JU, Heath PT. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia. Cochrane Database Syst Rev. 2011:CD001834. doi:10.1002/14651858.CD001834.pub3. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
